Influencia de la psiconeuroinmunoendocrinología en mujeres con cáncer de mama en SOLCA desde enero del 2019 a enero 2020.

Abstract

Introduction: Psychoneuroimmunoendocrinology (PNIE) is a discipline that encompasses different support therapies to improve immunity and quality of life in patients with breast cancer. Objectives: To relate the Psychoneuroimmunoendocrinology (PNIE) as an additional therapy in the treatment of depression in patients with breast cancer. Methodology: The present study has a cross-sectional, retrospective, observational, descriptive design. The population was made up of patients who attend the SOLCA Guayaquil Hospital outpatient consultation, in the period from January 2019 to January 2020. Results: The support treatment used together with the pharmacological one was laughter therapy. The patients were approached prior to taking laboratory samples. It was determined that the lymphocyte values remained fluctuating within normal parameters at 3 months after the intervention compared to the values during the period prior to supportive therapy. Conclusions: It was evidenced in the period from January 2019 to September 2019 that 60% of the patients subjected only to pharmacological treatment did not improve the percentage of lymphocytes. However, patients undergoing drug therapy combined with supportive therapy (laughter therapy) improved the percentage of lymphocytes (normal range between 20% to 50%) in 68% of the cases from October 2019 to January 2020.